Implementing a Bayesian approach using Stan with Torsten: Population pharmacokinetics analysis of somatrogon
CPT: Pharmacometrics & Systems Pharmacology · 2025
DOI: 10.1002/psp4.13279 ↗Kurz gefasst
Fachartikel in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, 2025. Verfasst von Yuchen Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pfizer Inc., South San Francisco, California, USA. Hauptthemen laut MEDLINE: Models, Biological, Software, Human Growth Hormone. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Fully Bayesian approaches are not commonly implemented for population pharmacokinetic (PK) modeling. In this paper, we evaluate the use of Stan with R and Torsten for population PK modeling of somatrogon, a recombinant long‐acting growth hormone approved for the treatment of growth hormone deficiency. As a software for Bayesian inference, Stan provides an easy way to conduct MCMC sampling for a wide range of models with efficient sampling algorithms, and there are several diagnostic tools to evaluate the MCMC convergence and other potential issues. Three different sets of priors were evaluated for estimation and prediction: a weakly informative uniform set, a moderately informative set, and a very informative set of priors. All three prior sets showed good performance and all chains mixed well. There were some minor differences in the final parameter posterior distributions while implementing different prior sets, but the posterior predictions covered the observations nicely, not only for the individuals included in posterior sampling but also for new individuals. The impact of a centered versus non‐centered parameterization were evaluated, with the non‐centered approach improving the estimation time, but it was still computationally intensive. Computational resources had the biggest impact on sampling time. Stan took approximately 2.5 h total for the MCMC sampling on a high‐performance computing platform (6 cores) and may be reduced further with additional computational resources. The model and comparisons presented show that with adequate computational resources, the Bayesian approaches using Stan and Torsten are useful for population PK analysis, especially for the analysis of special populations, small sample datasets, and when complex model structures are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pfizer Inc., South San Francisco, California, USA.
- Department of Statistics, Purdue University, West Lafayette, Indiana, USA.
- Pfizer Inc., Collegeville, Pennsylvania, USA.
- Pfizer Inc., Cambridge, Massachusetts, USA.
ORCID-Profile: Yuchen Wang, Xinyi Pei, Tao Niu, Joan Korth-Bradley, Luke Fostvedt
Zitieren
APA
Wang, Y., Pei, X., Niu, T., Korth-Bradley, J., & Fostvedt, L. (2025). Implementing a Bayesian approach using Stan with Torsten: Population pharmacokinetics analysis of somatrogon. CPT: Pharmacometrics & Systems Pharmacology. https://doi.org/10.1002/psp4.13279
Vancouver
Wang Y, Pei X, Niu T, Korth-Bradley J, Fostvedt L. Implementing a Bayesian approach using Stan with Torsten: Population pharmacokinetics analysis of somatrogon. CPT: Pharmacometrics & Systems Pharmacology. 2025. doi:10.1002/psp4.13279
BibTeX
@article{Wang2025,
author = {Wang, Yuchen and Pei, Xinyi and Niu, Tao and Korth-Bradley, Joan and Fostvedt, Luke},
title = {Implementing a Bayesian approach using Stan with Torsten: Population pharmacokinetics analysis of somatrogon},
journal = {CPT: Pharmacometrics & Systems Pharmacology},
year = {2025},
doi = {10.1002/psp4.13279}
}
EUVIMED